linsidomine has been researched along with Hypertrophy, Left Ventricular in 1 studies
linsidomine: RN given refers to parent cpd; structure
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Left ventricular hypertrophy (LVH) produced by aortic valve plication leads to increased myocardial cyclic GMP." | 3.69 | Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy. ( Sadoff, JD; Scholz, PM; Tse, J; Weiss, HR, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sadoff, JD | 1 |
| Scholz, PM | 1 |
| Tse, J | 1 |
| Weiss, HR | 1 |
1 other study available for linsidomine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
Topics: Animals; Arginine; Cyclic GMP; Dogs; Female; Guanylate Cyclase; Hypertrophy, Left Ventricular; Male; | 1996 |